Winifred S. Hayes, RN, PhD, ANP, Founder and CEO

Dr. Hayes founded Hayes, Inc. in 1989 in response to a growing need in the healthcare industry for evidence-based assessments of health technologies. Under her leadership, Hayes, Inc. has become an industry leader in providing unbiased, timely, clinically focused, evidence-based research and analysis to health plans, insurers, hospitals, healthcare systems, ACOs and government agencies. In June 1999, in response to the public outcry for independent, external medical review within the healthcare industry, Dr. Hayes formed Hayes Plus, a national Independent Review Organization. She sold the company in October 2005 after it was firmly established in the marketplace.

Recent Posts

Evidence and Value-Based Purchasing for Value Analysis. Part 3 of 4.

Welcome back for part 3 of our 4-part series! We’re just past the halfway mark in our effort to tell you about the impact of evidence on value-based purchasing (VBP). If you found the previous installments informative, please share these blogs with your fellow supply chain and value analysis professionals. Don’t forget, you can also download our free eBook, Evidence: The 5th Domain of Value-Based Purchasing to read the content of this series in one complete package.

Need to catch up? Here’s part 2.

Let’s review our third VBP domain: Clinical Care (Outcomes and Process).

Read More

Topics: Hospitals, Hayes Blog, Healthcare Evidence

Evidence and Value-Based Purchasing for Value Analysis. Part 2 of 4.

Welcome back for part 2 of our 4-part series about the impact of evidence on value-based purchasing (VBP). We hope you found the first installment informative, and that you shared it with your fellow supply chain and value analysis professionals. Don’t forget, you can download our free eBook, Evidence: The 5th Domain of Value-Based Purchasing to read the content of this series in one complete package.

Need a refresher for part 1? Read it here.

Let’s move on to our next VBP domain: Efficiency and Cost Reduction.

Read More

We Keep Talking About Evidence…So What Is It?

If you are a subscriber to our blog or any of our services (and if you aren’t, what are you waiting for?), it is no secret that we talk quite a bit about evidence and its vital necessity to the advancement of healthcare delivery. But without establishing some context by defining it, exploring what makes good evidence, and why it is important, our conversations about evidence can seem empty; the word becomes just another term in our promotional materials. With that, let us take a deeper look at what scientific evidence is and why it is the foundation of what we do here at Hayes.

Read More

Evidence and Value-Based Purchasing for Value Analysis. Part 1 of 4.

There’s been much conversation recently about the fate of value-based purchasing and the move from fee-for-service to outcomes-based medicine. Established by the Patient Protection and Affordable Care Act (ACA), the Hospital Value-Based Purchasing (VBP) Program is an initiative set forth by the Centers for Medicare & Medicaid Services (CMS) to provide acute-care hospitals with incentive payments based on the quality of care provided to their Medicare beneficiaries. These payments are based not only on how well the hospitals perform on each approved measure, but also on how much they improve compared with their performance that was established during a predetermined baseline period.

Read More

Critical Evidence Appraisal: There’s a Method(ology) to Our Madness

If you are a regular reader of our blog, you know we use a number of terms quite often. Fiercely unbiased. Critical appraisal. Scientific rigor.

But whether you’re a payer or a provider, a current or potential client: what does any of that mean to you? Why are these terms important, and how can the fact that they make up the DNA of what we do enhance your coverage policy determination and value analysis and value-based purchasing initiatives?

Read More

What Is the Role of Value Analysis in Bundled Payment Success?

Last week, I had the distinct privilege of presenting the keynote at the first annual Northeast Regional Conference of the Association of Healthcare Value Analysis Professionals (AHVAP). With the ever-increasing push away from fee-for-service and toward value-based healthcare, I thought it pertinent to discuss the role of value analysis in the success of a health system’s bundled payment initiatives. Specifically, I wanted to highlight the role evidence can play in assisting value analysis professionals in their evidence-based decision making, as well as how it can help them define the part they play in the value-based purchasing environment.

Read More

Topics: Health Technologies, Hospitals, Hayes Blog

“Dumb Data”: If I Only Had a Brain

In early March, Becker’s Hospital Review reported that MD Anderson Cancer Center placed their Oncology Expert Advisor project on hold. Announced in 2013, the joint effort between the hospital and the software giant was to be a revolutionary step forward in the use of “big data” to significantly improve clinical decision making and healthcare delivery. The article cites a number of reasons as to why the initiative was sidelined, not the least of which was cost. However, according to the article, a far more interesting complication arose involving MD Anderson’s electronic health record (EHR) system, which was changed after the program had begun. IBM Watson’s technology no longer communicated with the new EHR system and therefore had outdated information.   

Read More

Topics: Health Technologies, Hospitals, Hayes Blog

Big Data, MACRA, and Evidence: What’s the link?

By now, it’s probably safe to say that some, if not all, of you have experienced some level of “big data fatigue.” The phrase has become ubiquitous, no matter the industry, although it seems none more so than in healthcare. Indeed, almost every healthcare news source to which I subscribe these days seems to have weekly articles, essays, white papers and blogs about big data. But there’s a common thread often missing from these reports. While they all report on the inevitability of big data’s influence on the healthcare sphere, as well as the manner in which electronic health/medical records (EHR/EMR) will continue to impact the future of care delivery, there is little discussion of the role of evidence as it relates to big data.

Read More

Topics: Hospitals, Hayes Blog, Healthcare Evidence, Medicare

Evidence-Based Medicine and the Necessity of Science

Posted by Winifred S. Hayes, RN, PhD, ANP, Founder and CEO on February 1, 2017

There’s no disputing that the current state of healthcare is in flux. Regardless of public opinion and political leanings about the topic, the manner in which clinicians and health systems deliver care is changing, and more disruption to long-accepted paradigms is on the horizon. Though the move away from fee-for-service medicine has been in existence for some time, the adoption of an evidence-based approach in the provider market has been uneven at best. Perhaps now more than ever, a refocusing is required on just what evidence-based medicine (EBM) is, and why the application of the scientific method to healthcare delivery is essential to achieving the crucial Triple Aim.

Read More

Topics: Hospitals, Hayes Blog, Healthcare Evidence, Health Technology Assessments,, Medicare

The Hayes Year in Review

Posted by Winifred S. Hayes, RN, PhD, ANP, Founder and CEO on December 27, 2016

2016 marked a banner year for our company. We are humbled by the loyalty of our ever-expanding client roster. At the same time, we take great pride in what we’ve accomplished over the last 12 months and we’d like to share some of those endeavors with you here. If you’re new to Hayes, or not yet a member, we invite you to view just a sample of the innovation and growth we’ve experienced as an indication of things to come.

So without further ado…

Read More

Topics: Payers, Hospitals, Hayes Blog, Genetic Testing, Health Technology Assessments,